PTSD

Virtue Recovery Center in Houston Announces Partnership as Community-Approved Provider with the VA

Retrieved on: 
Monday, February 12, 2024

HOUSTON, Feb. 12, 2024 /PRNewswire-PRWeb/ -- Virtue Recovery Center in Houston Launches Specialized Programs for Veterans

Key Points: 
  • Virtue Recovery Center in Houston announces significant development for the center and the Veteran community.
  • Virtue Recovery Center in Houston is partnered with the Department of Veterans Affairs as a community-approved provider.
  • Virtue Recovery Center, a leading addiction treatment facility in Houston, is proud to announce its partnership with the Houston Veterans Affairs as a VA Community Approved Provider.
  • Understanding Veterans' complex needs, Virtue Recovery Center Houston offers a program that simultaneously addresses multiple treatment modalities.

Tonix Pharmaceuticals Announces FDA IND Clearance for DoD Funded Trial of TNX-102 SL for the Reduction of Acute Stress Reaction and Prevention of PTSD

Retrieved on: 
Monday, February 12, 2024

CHATHAM, N.J., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for the Phase 2 investigator-initiated OASIS trial to evaluate TNX-102 SL1 in reducing the severity of acute stress reaction (ASR) and the frequency of acute stress disorder (ASD) and posttraumatic stress disorder (PTSD). The trial is sponsored by The University of North Carolina (UNC) Institute for Trauma Recovery and supported by a $3 million grant from the U.S. Department of Defense (DoD).

Key Points: 
  • “There is an unmet need for treating ASR after traumatic events such as civilian motor vehicle collisions or warfighter experiences in forward bases or in theater.
  • Participants will be randomized in the ED to receive a two-week course of either TNX-102 SL 5.6 mg or placebo.
  • The OASIS trial will build upon a foundation of knowledge and infrastructure developed through the UNC-led, $40 million AURORA initiative.
  • AURORA is a major national research initiative to improve the understanding, prevention, and recovery of individuals who experience a traumatic event.

Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video

Retrieved on: 
Monday, February 12, 2024

Additionally, Optimi is pleased to unveil a six-minute video showcasing its end-to-end GMP MDMA encapsulation and production process.

Key Points: 
  • Additionally, Optimi is pleased to unveil a six-minute video showcasing its end-to-end GMP MDMA encapsulation and production process.
  • The FDA's priority review designation underscores the significance of this potential breakthrough in providing effective treatment options for those impacted by this debilitating condition.
  • Bill Ciprick, CEO of Optimi Health, stated, "We commend Lykos Therapeutics and MAPS founder, Rick Doblin, for their unwavering dedication to advancing innovative therapies for PTSD.
  • Stevens stated, "The ability to showcase our GMP MDMA production process is a testament to our commitment to excellence and transparency.

MAPS Congratulates Lykos Therapeutics on Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSD

Retrieved on: 
Saturday, February 10, 2024

"Thirty-eight years ago, one of my primary motivations for founding MAPS was to carve a path for psychedelic-assisted therapies to become FDA-approved treatments.

Key Points: 
  • "Thirty-eight years ago, one of my primary motivations for founding MAPS was to carve a path for psychedelic-assisted therapies to become FDA-approved treatments.
  • We hope that potential FDA approval of MDMA-assisted therapy for PTSD is only the first of many psychedelic-assisted therapies that become available by prescription."
  • Neither MDMA-assisted therapy for PTSD, nor any other psychedelic-assisted therapy, has been established for the treatment of any mental health condition.
  • The safety and efficacy of MDMA-assisted therapy have not been established for the treatment of PTSD.

Black men’s mental health concerns are going unnoticed and unaddressed

Retrieved on: 
Wednesday, February 7, 2024

A lawyer for his family said that he was dealing with a mental health crisis and was not a threat to anyone.

Key Points: 
  • A lawyer for his family said that he was dealing with a mental health crisis and was not a threat to anyone.
  • The incident also shines a light on the mental health concerns among Black men, which too often go unnoticed and unaddressed.
  • There seems to be a lack of urgency to address the mental health concerns of Black men in Canada, which can result in horrifying and deadly encounters with police.

Anti-Blackness as a mental health concern

  • Discussing mental health concerns is important, but we should avoid seeing them as a monolith.
  • Specific mental health concerns can impact a person’s physical and emotional well-being differently, but also their ability to recover and rehabilitate.
  • Although challenges with mental health can impact anyone, we must recognize that dealing with specific mental health issues can be uniquely different, and recovery and treatment can vary between people.

Black men and mental health

  • These feelings and negative stereotypical notions of Black masculinity can hinder Black men and boys’ ability to develop healthy perceptions of themselves and other Black men and boys.
  • The constant pressures Black men and boys face from negative police encounters leads many to avoid police.
  • This lack of engagement leaves mental illnesses among Black men and boys unresolved and reoccurring.
  • Consequently, Black men and boys who are suffering from mental health concerns will more likely have negative encounters with police.

Recognizing Black men’s suffering

  • As a result of stereotyping and social ostracization, there has been a sustained misunderstanding and misconception of Black men and boy’s lived experiences.
  • Recognizing the unique obstacles Black men and boys face is the first step toward this engagement.


Warren Clarke does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

ByteDance Offers Employees New VR Therapy Benefits With XRHealth

Retrieved on: 
Wednesday, February 7, 2024

XRHealth, the leading healthcare platform in Spatial computing, announced today that ByteDance will offer their employees new VR therapy benefits with XRHealth.

Key Points: 
  • XRHealth, the leading healthcare platform in Spatial computing, announced today that ByteDance will offer their employees new VR therapy benefits with XRHealth.
  • The employees will have access to XRHealth’s physical, occupational, and behavioral therapies from the comfort of their homes or at the ByteDance clinics.
  • “XRHealth is a solution of choice for corporate employees because employees have a higher rate of treatment plan adherence with our solution since it is fun, engaging, and convenient,” says Eran Orr, Chief Executive Officer of XRHealth.
  • "ByteDance aims to provide our employees with meaningful and effective benefits,” says Todd Wells, ByteDance’s Americas benefit leader.

Empatica’s Medical-Grade EmbracePlus Wearable Selected for Critical US Department of Defense PTSD Treatment Study

Retrieved on: 
Wednesday, February 7, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240207936228/en/
    EmbracePlus by Empatica has been selected by the US Department of Defense to monitor participants in a study on PTSD (Graphic: Business Wire)
    The Phase 2, randomized, double-blinded, placebo-controlled study will evaluate multiple potential pharmacotherapeutic interventions for PTSD in active-duty service members and veterans.
  • PTSD is a mental health condition that is triggered by a traumatic event that happens to or is witnessed by an individual.
  • The challenges posed by PTSD are substantial, both for those who serve and for all who face traumatic life events.
  • To learn more about EmbracePlus and the Empatica Health Monitoring Platform, please visit us at https://www.empatica.com/ .

Ibogaine By David Dardashti Offers Free Online Support for Post-Treatment Care

Retrieved on: 
Tuesday, February 6, 2024

To help those who have already completed treatment, Ibogaine By David Dardashti is now offering free online support for those in need.

Key Points: 
  • To help those who have already completed treatment, Ibogaine By David Dardashti is now offering free online support for those in need.
  • “At Ibogaine By David Dardashti, we strive to provide the highest level of care and nurturing to those who are fighting addiction or mental health issues,” said Dr. David Dardashti.
  • That’s why we’ve implemented this free online support program.” The free online support program will provide clients with counseling and support in the months following treatment.
  • Ibogaine By David Dardashti encourages anyone who has recently completed treatment to take advantage of their free online support program.

Talkiatry Named to the New York Digital Health 100 by Digital Health New York (DHNY)

Retrieved on: 
Tuesday, February 6, 2024

NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Talkiatry, a leading provider of high-quality, in-network psychiatric care, today announced that it has been named to the 2024 New York Digital Health 100 (DH100), a recognition that highlights the most exciting and innovative startups in New York. Digital Health New York (DHNY) publishes the annual list in conjunction with the New York Healthcare Innovation Report which takes an in-depth look at the investment trends, opportunities and challenges in the digital health sector.

Key Points: 
  • NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Talkiatry , a leading provider of high-quality, in-network psychiatric care, today announced that it has been named to the 2024 New York Digital Health 100 (DH100), a recognition that highlights the most exciting and innovative startups in New York.
  • Digital Health New York (DHNY) publishes the annual list in conjunction with the New York Healthcare Innovation Report which takes an in-depth look at the investment trends, opportunities and challenges in the digital health sector.
  • "The digital health landscape in New York City is dynamic, and it's an honor to be recognized amongst our peers on the New York Digital Health 100 list for the second year in a row," said Robert Krayn, co-founder and CEO, Talkiatry.
  • "2024 marks the fifth year of the New York Digital Health 100 and in that time, the digital health ecosystem in New York has significantly grown and evolved," said Bunny Ellerin, co-founder and CEO, DHNY.

Relief Mental Health Expands Access to Treatment: IV Ketamine Now Available in Additional Chicagoland Clinics

Retrieved on: 
Tuesday, February 6, 2024

Relief Mental Health , a leading provider of innovative mental health treatments, announced today the expansion of IV ketamine to multiple clinics across the Chicagoland area, including Chicago West Loop, Northbrook, Oak Brook , Orland Park and St. Charles.

Key Points: 
  • Relief Mental Health , a leading provider of innovative mental health treatments, announced today the expansion of IV ketamine to multiple clinics across the Chicagoland area, including Chicago West Loop, Northbrook, Oak Brook , Orland Park and St. Charles.
  • "We are pleased to extend our IV ketamine services to additional clinics throughout Chicagoland," said Susan Mueller, CEO, Relief Mental Health.
  • The decision to expand IV ketamine treatment services reflects Relief’s commitment to providing comprehensive, personalized care to patients in need.
  • Relief Mental Health remains steadfast in its dedication to promoting mental wellness and empowering individuals to reclaim their lives from the grips of mental illness.